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1Laboratory of Auditory Cell Biology, Department of Head & Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CaliforniaABSTRACT There is strong evidence that changes in the actin/spectrin-based cortical cytoskeleton of outer hair cells (OHCs)
regulate their motile responses as well as cochlear amplification, the process that optimizes the sensitivity and frequency selec-
tivity of the mammalian inner ear. Since a RhoA/protein kinase C (PKC)-mediated pathway is known to inhibit the actin-spectrin
interaction in other cell models, we decided to investigate whether this signaling cascade could also participate in the regulation
of OHC motility. We used high-speed video microscopy and confocal microscopy to explore the effects of pharmacological acti-
vation of PKCa, PKCbI, PKCbII, PKCd, PKCε, and PKCz with lysophosphatidic acid (LPA) and their inhibition with bisindolylma-
leimide I, as well as inhibition of RhoA and Rho-associated protein kinase (ROCK) with C3 and Y-27632, respectively. Motile
responses were induced in isolated guinea pig OHCs by stimulation with an 8 V/cm external alternating electrical field as
50 Hz bursts of square wave pulses (100 ms on/off). We found that LPA increased expression of PKCa and PKCz only, with
PKCa, but not PKCz, phosphorylating the cytoskeletal protein adducin of both Ser-726 and Thr-445. Interestingly, however, in-
hibition of PKCa reduced adducin phosphorylation only at Ser-726. We also determined that LPA activation of a PKCa-mediated
signaling pathway simultaneously enhanced OHC electromotile amplitude and cell shortening, and facilitated RhoA/ROCK/
LIMK1-mediated cofilin phosphorylation. Altogether, our results suggest that PKCa-mediated signals, probably via adducin-
mediated inhibition of actin-spectrin binding and cofilin-mediated depolymerization of actin filaments, play an essential role in
the homeostatic regulation of OHC motility and cochlear amplification.INTRODUCTIONOuter hair cells (OHCs) have the ability to continuously
adjust their total length and the amplitude of their electri-
cally induced somatic movements to optimize the sensitivity
and frequency selectivity of the mammalian cochlea (1). We
have used the term ‘‘mechanical homeostasis’’ to identify
this process (2), and our previous studies provided strong
evidence that it involves finely regulated cytoskeletal
changes mediated by Rho GTPases (2–5).
The hypothesis that the cytoskeleton is the essential struc-
ture involved in the mechanical homeostasis of OHCs is
supported by experiments showing that activation or inhibi-
tion of RhoA/Rho-associated protein kinase (ROCK)-medi-
ated pathways have a profound influence on the motile
response of OHCs (2,3,5). In particular, we demonstrated
that actin depolymerization, regulated by activation/inhibi-
tion of a RhoA/ROCK/LIMK1/cofilin-mediated pathway,
has a pivotal role in OHC motility (5). Among other find-
ings, it was reported that ROCK activation by RhoA induced
phosphorylation of the cytoskeletal protein adducin at
Thr-445 and Ser-726 in isolated OHCs (2). In other cell
populations, adducin was reported to promote actin-
spectrin binding after being phosphorylated at Thr-445 bySubmitted December 31, 2014, and accepted for publication March 23,
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ing after being phosphorylated at Ser-726 by RhoA/protein
kinase C (PKC)-mediated signals (7,8). Thus, the simulta-
neous detection of adducin phosphorylation at Thr-445
and Ser-726 in OHCs suggests that the adducin-mediated
continuous assembly and disassembly of the actin-spectrin
meshwork could dynamically regulate the structure of the
OHC cortical cytoskeleton (2).
In mammals, PKCs are a family of at least 12 isoenzymes
divided into four structurally and functionally distinct sub-
groups with variable distribution among different tissues
and cell types (9,10). PKCa, PKCb, and PKCg represent
conventional PKCs. Members of this subgroup are activated
by a combination of Ca2þ, diacylglycerol (DAG), and phos-
pholipid binding to specific domains. A subgroup of novel
PKCs includes PKCd, PKCε, PKCq, and PKCh, which are
similarly activated by DAG and phospholipids, but do not
respond directly to Ca2þ. The atypical PKCs PKCi and
PKCz do not depend on Ca2þ or DAG for activation, and
instead are allosterically activated by an interaction with
the partitioning defective 6 (PAR6)-CDC42 complex, which
is involved in specifying cell polarity.
Adducin is a tetrameric protein that consists of a/b or a/g
heterodimers (where a, b, and g are subunits originating
from three different genes with several different splice var-
iants). Adducin has been proposed to function as a crucial
assembly factor for the cytoskeletal network because ithttp://dx.doi.org/10.1016/j.bpj.2015.03.044
2172 Park and Kalinecpromotes the binding of spectrin to actin, two molecules
with a natural low affinity. When Ser-726 in adducin is
phosphorylated by PKCs, its affinity for actin and spectrin
is significantly reduced (7), destabilizing the actin-spectrin
membrane-associated cytoskeleton. To our knowledge, our
laboratory was the first to immunolocalize adducin in
cochlear OHCs and to suggest it could have an important
role in the dynamics of the OHC cortical cytoskeleton (2).
Although studies have provided evidence that stimulation
with lysophosphatidic acid (LPA) would cause adducin
phosphorylation, the potential involvement of PKCs in the
regulation of OHC motility has never been explored. In
this work, we stimulated isolated guinea pig OHCs with
an external alternating electrical field (EAEF) and used
video and confocal microscopy techniques to investigate
this issue and to identify the putative PKC isoform involved
in this process. Our results confirm that PKC-mediated sig-
nals regulate OHC motility, indicate that PKCa is the rele-
vant isoform, and strongly suggest that two signaling
cascades, RhoA/ROCK/PKCa/adducin and RhoA/ROCK/
LIMK1/cofilin, work coordinately in the fine regulation of
OHCs’ motile responses.MATERIALS AND METHODS
Isolation of OHCs
Cochleae were obtained from young guinea pigs (200–300 g) euthanized
with CO2 in accordance with the recommendations of the 2013 Report of
the American Veterinary Medical Association Panel on Euthanasia.
Cochlear spirals were placed in Leibowitz L-15 medium (Gibco-Invitrogen,
Grand Island, NY) containing 1 mg/mL collagenase (type IV; Sigma, St.
Louis, MO), and incubated at 31C for 3 min. The organ of Corti was
removed from the bone with fine needles and OHCs were mechanically
dissociated by reflux through the needle of a 50 mL syringe (Hamilton,
Reno, NV). Isolated OHCs were then moved to a recording chamber
(PCCS1; Bioscience Tools, San Diego, CA) filled with L-15, and observed
with the use of Nomarski differential interference contrast optics on an Ax-
iovert 135TV inverted microscope with a 63/1.2 C-Apochromat objective
(Carl Zeiss, Jena, Germany). Only live OHCs that met established health
criteria (11) were used for motility measurements.OHC motility measurements
Isolated OHCs were suspended in Leibovitz L-15 medium in a perfusion
chamber on an Axiovert 135 inverted microscope stage. Continuous
perfusion of an external solution consisting of L-15 adjusted to 300
mOsm with distilled water was provided at a rate of 0.3 mL/min using
a syringe pump. A full description of the equipment and procedures
used to measure OHC electromotility with an EAEF is available in the
literature (12,13). Briefly, suspended OHCs were placed in the experi-
mental dish between two silver wire electrodes (f ¼ 0.25 mm) with a
tip distance of 0.8 mm. An 8 V/cm EAEF was applied between electrodes
as 50 Hz bursts of square wave pulses (100 ms on/off). The cells’ longi-
tudinal axes were kept parallel to the applied EAEF by rotating the
recording chamber. Illumination provided by an LED light source
(High Power LED System 36AD3500; Lightspeed Technologies, Camp-
bell, CA), electrical stimulation, and image capture were digitally syn-
chronized (12,13). The osmolarity of every solution used in these
experiments was controlled and adjusted with distilled water or glucoseBiophysical Journal 108(9) 2171–2180to 300 5 2 mOsmol with a mOsmette 5004 freezing-point osmometer
(Precision Systems, Natick, MA).Video analysis and data handling
Images of isolated OHCs were captured in AVI format at 1000 frames/s
(fps) using the ultra-high-speed Photron Fastcam X 1024 PCI camera (Pho-
tron USA, San Diego, CA). Cell images were analyzed offline using ProA-
nalyst software (Xcitex, Cambridge, MA) and further processed using
Excel software (Microsoft, Redmond, WA) (12,13). Statistical analysis
with ANOVA techniques was performed using JMP 9 software (SAS Insti-
tute, Cary, NC), and p % 0.05 was used as the criterion for statistical
significance.Immunolabeling
Excised cochlear spirals were incubated for variable periods in either L-15
alone (control) or with the following agents (alone or combined): 10 mM
LPA (Sigma-Aldrich, Saint Louis, MO), 1 mM or 10 mM bisindolylmalei-
mide I (BIM-1; Calbiochem, La Jolla, CA), 1 mM 12-O-tetradecanoylphor-
bol-13-acetate (TPA; Sigma), 100 mg/mL C3 (Cytoskeleton, Denver, CO),
10 mMY27632 (Upstate Biotechnology, Lake Placid, NY), and 50 nM or 1
mM of H-89 (EMD Millipore, Darmstadt, Germany). OHCs dissociated
from cochlear spirals were moved to a petri dish with an uncoated glass
bottom (MatTek, Ashland, MA), fixed in 4% paraformaldehyde (EMS,
Fort Washington, PA) in phosphate-buffered saline for 2 h, and processed
for confocal microscopy. Anti-PKCa (C-20), anti-phosphorylated PKCa
(anti-p-PKCa; at Ser-657), anti-PKCbI (C-16), anti-PKCbII (C-18), anti-
PKCz (C-20), anti-PKCε (C-15), anti-PKCd (C-20), anti-RhoA (26C4),
anti-RhoC (G-12), anti-phosphorylated cofilin (anti-p-cofilin; at Ser-3),
anti-phosphorylated adducin (anti-p-adducin; at Ser-726), and anti-p-addu-
cin (at Thr-445) from Santa Cruz Biotechnologies (Santa Cruz, CA) were
used as primary antibodies at 1:100/1:200 dilutions. Alexa 488 (Molecular
Probes-Invitrogen, Eugene, OR) was used as secondary antibody at 1:500/
1:1000 dilutions. Actin was stained with rhodamine phalloidin (Molecular
Probes-Invitrogen, Eugene, OR). Samples were observed with a TSC-SP5
Broadband Spectra laser confocal microscope (Leica, Wetzlar, Germany)
with an HCX-PL 63/1.2 objective.RESULTS
LPA stimulates expression and activation of
PKCa in isolated guinea pig OHCs
We used confocal microscopy to investigate the expression
patterns of PKCa, PKCbI, PKCbII, PKCd, PKCε, and PKCz
in guinea pig OHCs. As shown in Fig. 1 A, all of these
PKC isoforms were found to be expressed in these cells.
PKCa, PKCbI, and PKCε showed strong and relatively ho-
mogeneous cytoplasmic expression, whereas expression of
PKCbII, PKCd, and PKCz was weaker and concentrated
mostly at the subcuticular organ, the perinuclear region,
and/or the infranuclear region (Fig. 1 A, arrows).
Next, we investigated the effects of LPA, a well-known
activator of Rho GTPases, and BIM-1, a potent cell-perme-
able and reversible pharmacological inhibitor of PKC
proteins (14–18), on the expression of PKCs in OHCs. Stim-
ulation of isolated OHCs with 10 mMLPA increased expres-
sion of PKCa and PKCz in these cells (Fig. 1 B), whereas
the immunoreactivity of other PKCs showed no changes
FIGURE 1 Immunolocalization of PKC isoen-
zymes and effect of BIM-1 on LPA-induced adducin
phosphorylation in isolated guinea pig OHCs. (A)
All PKC isoenzymes assayed were expressed in
guinea pig OHCs (primary antibodies, green;
DAPI, blue; rhodamine phalloidin, red). However,
labeling was stronger for PKCa, PKCbI, and
PKCε than for PKCbII, PKCd, and PKCz. In PKCbII
and PKCd, labeling was concentrated mostly at the
subcuticular organ and the infranuclear region,
whereas PKCz immunoreactivity was frequently
observed in the perinuclear region and below the
cuticular plate (arrows). (B) LPA increased PKCa
and PKCz immunolabeling in the OHCs’ cytoplasm
and nucleus. The effect on expression of PKCa, but
not PKCz, was prevented by pretreatment with
BIM-1. LPA-induced increase in PKCa expression
was associated with a similar increase in PKCa acti-
vation, as indicated by labeling with anti-p-PKCa at
Ser-657, but only in the cytoplasm; no activation was observed in nuclear PKCa (primary antibodies, green; rhodamine phalloidin, red). (C) LPA also
increased adducin phosphorylation of both Ser-726 and Thr-445 as indicated by reactivity to anti-p-adducin at Ser-726 and anti-p-adducin at Thr-445 an-
tibodies (green; DAPI, blue; rhodamine phalloidin; red). However, treatment with BIM-1 reduced adducin phosphorylation only at Ser-726. In all images,
scale bar ¼ 10 mm.
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OHCs to LPA with 1 or 10 mM of BIM-1 reduced PKCa
expression in a dose-dependent manner, but the effects on
PKCz expression were only evident in the cell nucleus
(Fig. 1 B). These results indicate that of all the PKC iso-
forms investigated in this study, PKCa was the only one
whose expression was upregulated by LPA and downregu-
lated by BIM-1 in the OHC cytoplasm. However, the in-
crease or decrease in expression was not equal to the
increased or decreased activation of the kinase. Therefore,
we investigated the effect of LPA and BIM-1 on PKCa
activation by labeling OHCs with antibodies targeting the
phosphorylated form of the enzyme. As shown in Fig. 1
B, labeling of PKCa and p-PKCa in the cytoplasm of
OHCs was correlated, with LPA enhancing and BIM-1
decreasing both PKCa expression and phosphorylation.
Interestingly, LPA increased immunolabeling of PKCa,
but not p-PKCa, in the cells’ nucleus. In the images of iso-
lated OHCs in Fig. 1 B, we blocked the blue channel (DAPI)
to make more evident the changes in nuclear expression
induced by the treatment.LPA stimulates adducin phosphorylation at both
Thr-445 and Ser-726, but BIM-1 only inhibits
phosphorylation at Ser-726
When we looked for additional effects of LPA treatment, we
found a significant increase in adducin phosphorylation at
Ser-726 and Thr-445 (Fig. 1 C), confirming a previous
finding of our laboratory (2). However, we also found that
preincubation with BIM-1 inhibited LPA-induced adducin
phosphorylation only at Ser-726 (Fig. 1 C), which agrees
with previous results from other laboratories indicating
that adducin phosphorylation at Thr-445 by LPA would bea PKC-independent process (19). Thus, we concluded that
PKCa is a mediator in the LPA-activated cascade that phos-
phorylates adducin at Ser-726.LPA-induced PKCa activation and adducin
phosphorylation would be mediated by RhoA
and ROCK
We investigated the involvement of Rho GTPases in the
signaling pathway activated by LPA, which induces
PKCa-mediated adducin phosphorylation at Ser-726. For
this purpose, in addition to BIM-1, we used the cell-perme-
able inhibitors C3 (an exoenzyme that selectively affects
the highly homologous Rho isoforms RhoA, RhoB, and
RhoC, but no other members of the family, such as Rac
and Cdc42 (20)), and Y27632 (a specific inhibitor of the
Rho kinase ROCK (21)). We found that both C3 (100
mg/mL) and Y27632 (10 mM) reduced the LPA-induced in-
crease in PKCa expression as well as adducin phosphory-
lation at Ser-726 (Fig. 2 A). These results suggest that the
signals that enhance PKCa expression and adducin phos-
phorylation at Ser-726 are mediated by Rho (A, B, or C)
and ROCK.
To identify the particular Rho GTPase involved in this
signaling cascade, we used antibodies against RhoA,
RhoB, and RhoC. We found that guinea pig OHCs express
RhoA and RhoC (Fig. 2 B), but not RhoB (not shown).
Interestingly, RhoC immunolabeling was more intense in
the cells’ nucleus than in the cytoplasm, and expression
levels were unchanged by treating the OHCs with 10 mM
of LPA. In contrast, RhoA expression was similar in the
cytoplasm and nucleus of untreated cells, but LPA dramat-
ically increased the reactivity to RhoA antibodies in the
OHCs’ nucleus, and this increase was visibly decreasedBiophysical Journal 108(9) 2171–2180
FIGURE 2 LPA-induced PKCa activation and
adducin phosphorylation require RhoA and
ROCK activation. Isolated guinea pig OHCs were
stimulated with 10 mM LPA alone or preincubated
with C3 (100 mg/ml), Y27632 (10 mM), or BIM-1
(10 mM) for 10 min before LPA stimulation. (A)
The RhoA inhibitor C3 and the ROCK inhibitor
Y27632 reduced PKCa expression and adducin
phosphorylation at Ser-726. (B) OHCs express
RhoA and RhoC, but only RhoA is stimulated by
LPA. LPA increased the reactivity to RhoA anti-
bodies in the OHCs’ nucleus, and this increase
was reduced by pretreatment with BIM-1. In
contrast, ROCK was expressed in the cytoplasm
and nucleus of untreated OHCs, and preincubation
with BIM-1 resulted in an evident increase in nu-
clear ROCK labeling. To better visualize the nu-
clear expression of RhoC, RhoA, and ROCK, the
images are shown in duplicate with and without
the blue (DAPI) channel. In all images, scale
bar ¼ 10 mm.
2174 Park and Kalinecby 10 mM of BIM-1 (Fig. 2 B). ROCK, on the other hand,
was expressed in the cytoplasm and nucleus of untreated
OHCs, and although LPA alone did not induce noticeable
changes in ROCK immunoreactivity in the nucleus or
cytoplasm, a 10 min preincubation with BIM-1 before
LPA treatment resulted in an evident increase in nuclear
ROCK labeling (Fig. 2 B). To better visualize the nuclear
expression of RhoA and ROCK, the images of isolated
OHCs in Fig. 2 B were duplicated with and without the
blue (DAPI) channel. These results suggest that althoughBiophysical Journal 108(9) 2171–2180RhoA and ROCK could indeed be upstream components
of the signaling cascade activated by LPA that induces ad-
ducin phosphorylation at Ser-726 in OHCs, they could also
be working downstream of PKCs (as suggested by experi-
ments in other cell models (22)) in a pathway associated
with RhoA expression in OHCs’ nucleus. However, the
LPA-induced changes in nuclear expression of RhoA and
ROCK would be not correlated with PKCa activation,
since no significant increase in immunoreactivity to anti-
p-PKCa was detected in the nucleus of OHCs that were
Regulation of Outer Hair Cell Motility 2175either untreated or treated with LPA alone or with LPA plus
BIM-1 (see Fig. 1 B).BIM-1 inhibits the changes in OHC motility
induced by LPA
Whereas the previous results indicate that LPA could acti-
vate a RhoA/ROCK/PKCa signaling cascade that induces
adducin phosphorylation at Ser-726, they do not provide
any evidence that this pathway could be involved in the
regulation of OHC motility. To address this issue, we inves-
tigated changes in total cell length and EAEF-induced elec-
tromotile amplitude in OHCs treated with LPA for 15 min,
with and without preincubation with BIM-1. As expected,
our experiments showed that LPA induced a significant in-
crease in the OHCs’ electromotile amplitude with respect
to the control condition, which was diminished by preincu-
bation with BIM-1 (Fig. 3, A and B). Moreover, BIM-1
alone (cells not treated with LPA) decreased the EAEF-in-
duced electromotile amplitude in a dose-dependent manner
(Fig. 3 C), suggesting that the RhoA/ROCK/PKCa pathway
is continuously at work, even in the absence of external LPA
stimulation, to regulate the motile response of cochlear
OHCs. As described in previous studies (4,13), under the
three experimental conditions the electromotile amplitude
increased with time, reached a plateau ~2 s after stimulation,
and then remained stable. Here, we report data obtainedfrom up to 3 s of electrical stimulation, the same final
time point used in the previous studies.
We also found that BIM-1 modulated the EAEF-induced
shortening of OHCs. Under our experimental conditions,
controlOHCs exposed to anEAEF contractedmonotonically
and showed a reduction of ~1.5% in total length after 3 s. In
contrast, in LPA-treated cells, cell length decreased by ~2.2%
in 1.6 s and then remained stable (Fig. 4 A). Preincubation
with 10 mMofBim-1 resulted in a response indistinguishable
from that of control cells up to 2 s of stimulation, but at this
point in time a sudden additional contraction drove the total
decrease in cell length to ~2.6% (Fig. 4, A and B). Moreover,
BIM-1 alone (cells not treated with LPA) decreased OHC
shortening in a dose-dependent manner (Fig. 4 C). These re-
sults suggest that the slow motility of OHCs is modulated by
PKCa-mediated signals, but other pathways could also be
controlling their slow somatic responses.
Since BIM-I is also an inhibitor of protein kinase A
(PKA), we wondered whether LPA’s effects on OHC
motility could be associated with this kinase rather than
with PKCa. To test this possibility, we used H-89, a potent
inhibitor that is 500-fold more selective for PKA than for
PKCs (23). Since its IC50 for PKA is 135 nM, we tested
the effect of H-89 concentrations ranging from 50 nM
to 1 mM on LPA-induced changes in OHC motility. We
detected no significant influence of H-89 on either OHC
electromotile amplitude or shortening (results not shown),FIGURE 3 Effect of PKCa inhibition on OHC
electromotile amplitude. OHCs were treated with
10 mM LPA alone for 15 min or preincubated
with BIM-1 (1 and 10 mM) before LPA stimulation,
and then electrically stimulated with an EAEF for
3 s. (A) Electromotile amplitude versus time in con-
trol (n ¼ 5), LPA-treated (n ¼ 5), and LPAþBIM-
1-treated (10 mM, n ¼ 5) OHCs. BIM-1 decreased
the LPA enhancing effect on OHC electromotile
amplitude. (B) Electromotile amplitude values (to-
tal cell length¼ 100%) at 3 s after the beginning of
the stimulation (mean5 SE): control ¼ 2.27%5
0.11%, LPA ¼ 2.78% 5 0.16% (p % 0.008),
LPAþBIM-1 (10 mM) ¼ 2.34% 5 0.16% (p ¼
N.S. with respect to both control and LPA). (C)
Electromotile amplitude of untreated cells (n ¼ 5)
and cells exposed to BIM-1 (1 or 10 mM) only
(n ¼ 4): control ¼ 2.27% 5 0.11%, BIM-1
(1 mM) ¼ 1.87% 5 0.14%, BIM-1 (10 mM) ¼
0.60%5 0.14% (p% 0.02 and p% 0.0001 re con-
trol, respectively, and p% 0.001 between them).
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FIGURE 4 Effect of PKCa inhibition on OHC
length. Electrically stimulated OHCs showed a
decrease in total length (slow motility). (A) OHC
shortening versus time in control (n ¼ 5), LPA
treated (n ¼ 5), and LPAþBIM-1-treated (10 mM,
n ¼ 5) OHCs. Whereas LPA increased cell short-
ening, pretreatment with BIM-1 partially modified
this response. (B) Cell shortening values (total cell
length ¼ 100%) at 3 s after the beginning of the
stimulation (mean 5 SE): control ¼ 1.51% 5
0.18%, LPA ¼ 2.18%5 0.18% (p% 0.01 re con-
trol), LPAþBIM-1 (10 mM) ¼ 2.64% 5 0.18%
(p % 0.0008 re control, N.S. re LPA alone). (C)
Shortening in untreated cells (n ¼ 5) and cells
exposed to BIM-1 (1 or 10 mM) only (n ¼ 4):
control ¼ 1.51% 5 0.18%, BIM-1 (1 mM) ¼
1.02% 5 0.10%, BIM-1 (10 mM) ¼ 0.64% 5
0.20% (p % 0.02 and p % 0.0001 re control,
respectively, and p% 0.01 between them).
2176 Park and Kalinecindicating that BIM-1 effects are associated mainly with in-
hibition of PKCa.PKCa influences cofilin phosphorylation
As shown in previous studies by our laboratory, LPA acti-
vates a RhoA/ROCK/LIMK1-mediated pathway that modu-
lates actin filament dynamics by phosphorylating cofilin (5).
Thus, it might be possible that the LPA effects described
above as being associated with activation of PKCa are
instead related to LPA-induced cofilin phosphorylation.
To address this issue,we usedTPA,which stimulates PKCa
activity but, unlike LPA, does not target RhoA or ROCK and
therefore should not stimulate LIMK1-mediated cofilin phos-
phorylation. As expected, we confirmed that TPA treatment
did not change ROCK expression and, importantly, did
not induce cofilin phosphorylation (Fig. 5 A). This result
was not surprising, since it is generally accepted that PKCs
do not phosphorylate cofilin, and the typical site of cofilin
phosphorylation, Ser-3, is not a consensus PKC phos-
phorylation site. Intriguingly, however, preincubation with
BIM-1 decreased LPA-induced immunoreactivity to p-cofilin
(Fig. 5A), suggesting that activation of PKCawas required for
the efficient phosphorylation of cofilin at Ser-3 induced by
LPA. On the other hand, TPA stimulated PKCa and PKCz
expression and adducin phosphorylation at Thr-445 and Ser-
726 just like LPA, and BIM-1 inhibited only PKCa activation
and adducin phosphorylation at Ser-726 (Fig. 5 B).Biophysical Journal 108(9) 2171–2180Thus, since BIM-1 inhibits PKCa and interferes with
LPA-induced, RhoA/ROCK/LIMK1-mediated cofilin phos-
phorylation, we speculate that PKCa is part of a still un-
known mechanism that facilitates cofilin phosphorylation
by LIMK1 (Fig. 6).DISCUSSION
OHC motility is the major mechanism underlying cochlear
amplification, the process that increases the sensitivity
and frequency discrimination of the mammalian cochlea
(1,24,25). Our goal in this studywas to obtain mechanistic in-
sights into the regulation ofOHCmotility, and hence cochlear
amplification, by the OHC cortical cytoskeleton. For about
three decades, the prevalent technique for investigating
OHC motility has been whole-cell voltage clamp. However,
the patch pipette not only disrupts the plasma membrane
but also affects the molecular organization and functional
response of the cortical cytoskeleton, the specific structure
whose influence on OHC motility we are trying to evaluate.
Thus, in this study we used an EAEF. In this technique, cell
movement is not constrained by any attachment to the rim
of a suction micropipette that could influence the mechanical
response of the OHC lateral wall, and the responses may be
entirely attributed to the interaction of the electrical field
with the cellular motile mechanism. Our findings indicate
that activation of a RhoA/ROCK/PKCa signaling cascade
with LPA results in adducin phosphorylation at Ser-726,
FIGURE 5 Effect of TPA on ROCK, PKCa, and PKCz expression and
adducin phosphorylation in OHCs. (A) Levels of ROCK expression were
not changed, but labeling of nuclear p-cofilin decreased significantly in
OHCs treated with TPA. LPA, in contrast, increased p-cofilin labeling
in the cytoplasm and nucleus of OHCs, whereas BIM-1 significantly
decreased LPA-induced cofilin phosphorylation. (B) Whereas TPA
increased expression of both PKCa and PKCz, BIM-1 inhibited this effect
only for PKCa. Similarly, TPA induced adducin phosphorylation at both
Ser-726 and Thr-445, but treatment with BIM-1 reduced adducin phosphor-
ylation only at Ser-726. In all images, scale bar ¼ 10 mm.
FIGURE 6 Cartoon representing LPA-activated signaling cascades that
regulate OHC motility, as suggested by our results and previous studies
(in black font), as well as potential mediators and interactions that require
confirmation (gray font). LPA activation of the RhoA/ROCK/LIMK1/cofi-
lin pathway would target actin-filament dynamics, enhancing actin depoly-
merization. In turn, activation of the RhoA/ROCK/PKCa/ adducin pathway
would phosphorylate adducin at Ser-726, inhibiting actin-spectrin binding.
However, these two signaling cascades would be working in parallel, with
PKCa facilitating cofilin phosphorylation by a still unknown mechanism.
The final result of the activation of these two signaling pathways would
be the same, i.e., a decrease in the integrity of the OHC actin/spectrin-based
cortical cytoskeletal network.
Regulation of Outer Hair Cell Motility 2177enhancement of the OHC electromotile amplitude, and mod-
ulation of the changes in the total OHC length (slowmotility).
Since adducin phosphorylation at Ser-726 inhibits actin-spec-
trin binding (7,8), we speculate that the changes in OHC
motile responses would be associated with a partial disinte-
gration of the actin-spectrin network lining the cytoplasmic
surface of the OHC lateral wall induced by LPA activation
of a RhoA/ROCK/PKCa/adducin signaling cascade. Impor-
tantly, in a previous report (5) we presented evidence indi-
cating that a regulatory mechanism of OHC motility relied,
at least in part, on the control of the depolymerization rate
of actin filaments by RhoA/ROCK/LIMK1/cofilin-mediated
signals. The study presented here further extends those re-
sults, suggesting that both pathways (RhoA/ROCK/PKCa/
adducin and RhoA/ROCK/LIMK1/cofilin) work together,
with PKCa activation facilitating LPA-induced cofilin phos-
phorylation mediated by the RhoA/ROCK/LIMK1 signaling
cascade (Fig. 6).RhoA/ROCK-mediated pathways
The control of actin dynamics, cytoskeletal reorganization,
cell motility, and migration in animal cells is concentratedin three members of the Rho family of small GTPases:
Rho, Rac, and Cdc42 (26–28). Since in this study we used
the specific cell-permeable Rho inhibitor C3, which inhibits
Rho, but not Rac or Cdc42, we conclude that the LPA-medi-
ated PKC activation pathway does not involve Rac or
Cdc42.
The three Rho isoforms (RhoA, RhoB, and RhoC) have
different expression and activation patterns, different bind-
ing activities and/or affinities for their target proteins, and
different subcellular localizations (28,29). RhoB is a
short-lived protein that, unlike RhoA and RhoC, is not
constitutively expressed but rather is induced by both phys-
ical and chemical agents (30). Thus, we were not surprised
that we could not detect RhoB in OHCs under our experi-
mental conditions. The functions of RhoA and RhoC, on
the other hand, are quite similar, although previous studies
suggested that they have different effects on cell mor-
phology, motility, and invasion because they act on differentBiophysical Journal 108(9) 2171–2180
2178 Park and Kalinecdownstream targets (28,29). Although both RhoA and RhoC
were found to be expressed in OHCs, this work as well as
previous studies point to RhoA as the mediator of LPA-acti-
vated signals in these cells.PKCa phosphorylates adducin at Ser-726 and
regulates OHC motility
Our results indicate that guinea pig OHCs express all of the
assayed PKCs (PKCa, PKCbI, PKCbII, PKCd, PKCε, and
PKCz), although with different abundances and patterns of
distribution. However, only the effects of LPA and TPA on
PKCa are both inhibited by BIM-1 and correlated with ad-
ducin phosphorylation at Ser-726, supporting the idea that
PKCa is the specific isoform involved in the LPA-activated
RhoA/ROCK/PKC-mediated signaling cascade that regu-
lates OHC motility.
We provide evidence that adducin phosphorylation at Ser-
726 correlates with an enhancement of the OHC electromo-
tile amplitude and changes in total cell length (slowmotility).
Although we are not demonstrating causality, the fact that
phosphorylation of adducin at Ser-726 is a well-known pro-
moter of actin-spectrin dissociation (7,8) strongly suggests
that both events are mechanistically linked. We performed
experiments on OHCs isolated from control and b-adducin
knockout (KO) mice, but confocal microscopy experiments
showed that b-adducin was replaced by g-adducin in the
KO animals, andwewere unable to detect any significant dif-
ference in cellmotility between the two groups (R.Kitani and
F.K., unpublished results). This was not a completely surpris-
ing result, since it was previously reported that deletion of b-
adducin results in its replacement by g-adducin in red blood
cells (RBCs), suggesting that a-adducin requires a heterolo-
gous binding partner for stability and function (31,32).
Although the sequences of b and g adducin have only 60–
70% similarity, they both have an N-terminal globular head
domain, a neck domain, and a C-terminal tail domain, with
a highly conserved 22-residue MARCKS-related domain at
the end of the C-terminal tail domain containing the major
phosphorylation site for PKCs (7). Therefore, we can specu-
late that PKCs phosphorylate g-adducin just like they phos-
phorylate b-adducin. However, RBCs in b-adducin KOmice
were osmotically fragile and microcytic, and had the pheno-
type of hereditary spherocytosis, whereas no evident struc-
tural changes were observed in OHCs. We speculate that
these different responses reflect the different structure of
the cortical cytoskeleton in RBCs and OHCs. In RBCs the
actin filaments are very short and interconnected by six to
eight spectrin molecules in a spiderweb-like fashion (33).
Therefore, even a partial malfunction of adducin in RBCs
may result in extensive structural failure. In OHCs, in
contrast, actin filaments are very long, nearly parallel, and in-
terconnected by spectrin molecules spaced ~30–40 nm along
the actin cables (34). Thus, adducin malfunction in OHCs
could be partially compensated for by just a low percentageBiophysical Journal 108(9) 2171–2180of strong actin-spectrin connections between parallel actin fi-
bers. Currently, we are investigating the motile responses of
OHCs from b/g-adducin double-KO mice to definitively
confirm the involvement of adducin in the regulation of
OHC motility.
Intriguingly, LPA also induced adducin phosphorylation
at Thr-445, which promotes actin-spectrin binding, via a
most likely PKCa-independent (not inhibited by BIM-1)
pathway. We speculate that adducin phosphorylation at
Thr-445 could be part of a safety mechanism aimed at
preventing a massive disintegration of the actin-spectrin
network that could compromise the OHC structure. This
speculation is supported by our results showing that inhibi-
tion of PKCa in LPA-treated cells maintained OHC motile
responses near control values, whereas PKCa inhibition in
untreated cells induced a very significant and dose-depen-
dent decrease in these responses. In previous studies (2,5)
we speculated that acetylcholine (ACh) would be able
to stimulate cofilin phosphorylation and OHC electromotil-
ity via a RhoA-dependent, ROCK-independent signaling
cascade, and modulate OHC slow motility by inhibiting co-
filin phosphorylation via the RhoA/ROCK pathway, exert-
ing a profound influence on cochlear amplification. The
potential interaction of ACh with the RhoA/ROCK/PKCa/
adducin pathway is currently being investigated.
Together with previous studies showing the pivotal role of
actin depolymerization, these results highlight the important
role of the cortical cytoskeleton in the regulation of OHC
motility.Role of the RhoA/ROCK/PKCa/adducin pathway
in the regulation of OHC motility
Our experiments showed that LPA induced a significant in-
crease in the OHC electromotile amplitude, which was
diminished by inhibiting PKCa (Fig. 3 B). Likewise, LPA
increased OHC shortening (slow motility) and PKCa inhibi-
tion modulated, but did not prevent, the LPA effect (Fig. 4, A
and B). Although a quantitative comparison of our results
with previous findings regarding activation and inhibition
of the RhoA/ROCK/LIMK1/cofilin pathway (5) is not
possible because of the different techniques and experi-
mental protocols used in the two studies (EAEF and
patch-clamp stimulation, 10 min and 3 s long, respectively),
they are clearly qualitatively similar. This is not a surprise,
since both processes (enhancing actin depolymerization via
RhoA/ROCK/LIMK1/cofilin and inhibiting actin-spectrin
binding via RhoA/ROCK/PKCa/adducin) have a similar
output, i.e., a decrease in the integrity of the OHC actin-
spectrin cortical cytoskeleton. Interestingly, in cells not
treated with LPA, PKCa inhibition decreased the EAEF-
induced electromotile amplitude and OHC shortening in a
dose-dependent manner (Figs. 3 C and 4 C), suggesting
that the RhoA/ROCK/PKCa/adducin pathway is continu-
ously at work to regulate the motile response of OHCs.
Regulation of Outer Hair Cell Motility 2179It has been suggested that in vascular smooth muscle
cells, TPA-induced PKC activation leads to Rho downregu-
lation and disassembly of actin filaments (22,35). Our ex-
periments indicate that in OHCs, LPA-mediated activation
of the RhoA/ROCK/LIMK1 signaling cascade requires
PKCa activation to induce cofilin phosphorylation and
hence disassembly of actin filaments. Thus, we speculate
that in OHCs, the RhoA/ROCK/LIMK1/cofilin and RhoA/
ROCK/PKCa/adducin pathways would work in parallel
and show an active cross talk (Fig. 6). This could be an
additional mechanism aimed at optimizing the homeostatic
control of the OHCs’ mechanical responses. Interestingly,
previous experimental evidence regarding the control of
spontaneous phasic activities in rectal smooth muscles
also suggested that PKC- and RhoA/ROCK-mediated path-
ways could be working in parallel, with an active cross talk
(36). Moreover, a recent study on the mechanism of degran-
ulation in rat basophilic leukemia-2H3 cells suggested a
possible mechanistic explanation for our results (37). In
that study, the authors used mass spectrometry and muta-
genic analyses to reveal that PKCa phosphorylates cofilin
at Ser-23 and/or Ser-24, but not at Ser-3. Other laboratories
have not yet confirmed this result, but if PKCa indeed
phosphorylates cofilin at Ser-23 and/or Ser-24, it could be
inducing conformational changes in the cofilin molecule
that facilitate the LPA-induced, LIMK-1-mediated cofilin
phosphorylation at Ser-3. Experimental approaches to
investigate this possibility in OHCs are currently being eval-
uated in our laboratory.How does the cytoskeleton network influence
OHC motor function?
A few years ago, we demonstrated that LPA stimulation has
no direct effect on prestin performance (5). In a subsequent
study, our laboratory provided evidence that the lateral wall
of guinea pig OHCs consists of discrete structural microdo-
mains that can move relative to each other and change their
orientation with respect to the cell axis (4). Thus, we spec-
ulate that LPA-induced activation of the RhoA/ROCK/
PKCa/adducin pathway, just like activation of the RhoA/
ROCK/LIMK1/cofilin signaling cascade, does not directly
affect prestin performance, but could be responsible for
the rearrangement of microdomains in the plane of the
plasma membrane and, probably, the organization or disor-
ganization of the motor units (prestin single molecules, di-
mers or tetramers) inside the microdomains. In this way,
the magnitude and/or direction of the vectorial component
of the force generated by every molecular motor unit would
depend on the cortical cytoskeleton.CONCLUSIONS
Using an EAEF rather than the classical whole-cell, patch-
clamp technique, which could influence the mechanicalresponse of the OHC lateral wall, we found that activation
of a RhoA/ROCK/PKCa signaling cascade with LPA re-
sulted in adducin phosphorylation at Ser-726, enhancement
of the OHC electromotile amplitude, and modulation of the
changes in total OHC length (slow motility). We speculate
that the changes in OHC motile responses are associated
with a partial disintegration of the actin-spectrin network
lining the cytoplasmic surface of the OHC lateral wall.
We also found that activation of PKCa may enhance LPA-
induced, RhoA/ROCK-mediated cofilin phosphorylation.
Thus, our results support the idea that the cytoskeleton plays
a crucial role in the regulation of OHCmotility, and strongly
suggest the existence of multiple control mechanisms that
work coordinately in the fine regulation of these motile re-
sponses and cochlear amplification.AUTHOR CONTRIBUTIONS
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